NCT06418971 Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.
| NCT ID | NCT06418971 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Caregiver Burden |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-09-15 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well being. The main aims of this study are: * To evaluate the feasibility and acceptability of the CarePair mobile application. * To explore the potential for CarePair to reduce feelings of depression and burden, and improve caregivers' feelings of self-efficacy. Caregiver participants will be asked to log in and use the CarePair application and complete study activities for a six-week duration. Researchers will compare the intervention group to an attention control comparator to see if application use is associated with improved psychosocial outcomes at follow-up.
Eligibility Criteria
Inclusion: * Currently a primary caregiver of a community-dwelling PwD * Provides at least 10 hours of care per week * ≥18 years of age * Fluent in English * Both the caregiver and care-recipient reside in and/or can easily access one of the following cities/areas: New York City, New York (NY); Long Island, NY; Westchester County, NY; Seattle, Washington (WA); Los Angeles, California (CA) * Provides at least 10 hours of care per week * Has provided care for at least 6 months * Able to use the internet and has internet access * Owns and can operate a smartphone * Able and willing to provide their informed consent to participate for the six-week study duration * Does not self-report any cognitive impairments Exclusion: * Not currently the primary caregiver of a community-dwelling person with dementia * Care-recipient lives in residential care (e.g., assisted living, skilled nursing facility) * ≤18 years of age * Not fluent in English * The caregiver and/or care-recipient resides outside of and/or cannot easily access any of the following cities: New York City (NY); Long Island (NY); Westchester County (NY); Seattle (WA); Los Angeles (CA) * Provides less than 10 hours of care per week * Has provided care for less than 6 months * Unable to use the internet or does not have internet access * Does not own and/or cannot operate a smartphone * Unable or unwilling to provide informed consent to participate for the six-week study duration * Self-reports having a cognitive impairment
Contact & Investigator
Francesca Falzarano, PhD
PRINCIPAL INVESTIGATOR
University of Southern California
Frequently Asked Questions
Who can join the NCT06418971 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Caregiver Burden. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06418971 currently recruiting?
Yes, NCT06418971 is actively recruiting participants. Contact the research team at falzaran@usc.edu for enrollment information.
Where is the NCT06418971 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06418971 clinical trial?
NCT06418971 is sponsored by University of Southern California. The principal investigator is Francesca Falzarano, PhD at University of Southern California. The trial plans to enroll 80 participants.